1. Home
  2. CXII vs AQST Comparison

CXII vs AQST Comparison

Compare CXII & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXII

Churchill Capital Corp XII Class A Ordinary Shares

N/A

Current Price

$10.49

Market Cap

597.4M

Sector

Finance

ML Signal

N/A

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

SELL

Current Price

$3.76

Market Cap

529.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CXII
AQST
Founded
2026
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
597.4M
529.4M
IPO Year
2026
2007

Fundamental Metrics

Financial Performance
Metric
CXII
AQST
Price
$10.49
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $9.33
AVG Volume (30 Days)
27.3K
★ 2.4M
Earning Date
N/A
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $67,430,000.00
Revenue This Year
N/A
$11.13
Revenue Next Year
N/A
$40.69
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 0.77
52 Week Low
$10.05
$2.94
52 Week High
$10.99
$6.74

Technical Indicators

Market Signals
Indicator
CXII
AQST
Relative Strength Index (RSI) 44.45 43.59
Support Level $10.34 $3.59
Resistance Level $10.45 $4.34
Average True Range (ATR) 0.03 0.25
MACD 0.02 0.02
Stochastic Oscillator 41.18 41.85

Price Performance

Historical Comparison
CXII
AQST

About CXII Churchill Capital Corp XII Class A Ordinary Shares

Churchill Capital Corp XII is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: